Study guide

16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context

NBRC Registered Pulmonary Function Technologist RPFT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Content Outline Domains & Study Plan

2 Spirometry Instrumentation

2.1 Spirometer Types, Setup & Maintenance 2.2 Spirometer Calibration & Linearity 2.3 Spirometer Troubleshooting

3 Blood Gas & Gas Analyzers

3.1 Blood Gas Analyzer Setup, Maintain, Calibrate 3.2 Gas Analyzers & Water/Gas Absorbers 3.3 ABG & Gas Analyzer Troubleshooting and QC

4 Body Box, Exercise & Monitoring Equipment

4.1 Body Plethysmograph Setup & Calibration 4.2 Exercise, Field Walking & ECG Equipment 4.3 Pressure Devices, Valves & Gas Delivery Systems

5 Ancillary Equipment & Infection Control

5.1 Body Habitus, Sampling & Aerosol Equipment 5.2 Monitors & Emergency Management Equipment 5.3 Infection Control Materials & Methods

6 Quality Control Systems

6.1 Mechanical QC Devices 6.2 Biological Controls & Proficiency Testing 6.3 Laboratory Quality Management & SOPs

7 Patient Preparation & Safety

7.1 Body Habitus Measurements & Estimates 7.2 Patient Safety, Precautions & Adverse Events

8 Spirometry Procedures

8.1 Selecting Spirometry Protocols & Equipment 8.2 Performing Standard & Position-Variant Spirometry 8.3 Evaluating Spirometry Acceptability & Repeatability 8.4 Bronchodilator Response Studies

9 Static Lung Volumes

9.1 Gas Dilution Lung Volume Methods 9.2 Body Plethysmography Lung Volumes 9.3 Evaluating Lung Volume Validity

10 Diffusing Capacity (DLCO)

10.1 DLCO Protocol & Equipment Selection 10.2 Performing the DLCO Maneuver 10.3 Evaluating DLCO Validity

11 Blood Gas Sampling & Analysis Procedures

11.1 Arterial & Capillary Blood Sample Collection 11.2 Performing Blood Gas Analysis 11.3 CO-oximetry / Hemoximetry Procedures

12 Airway Responsiveness, Resistance & Muscle Strength

12.1 Bronchial Provocation Studies 12.2 Airways Resistance & Conductance by Plethysmography 12.3 Respiratory Muscle Strength (MIP/MEP/CPF)

13 Exercise, Oxygen, Home Testing & Education

13.1 Field Walking Tests (6MWT, Shuttle) 13.2 Monitored Exercise Testing 13.3 Oxygen Assessment & Titration 13.4 Home Testing Instruction & Patient Education

14 Calculations & Reference Ranges

14.1 Spirometry Calculations & Reference Equations 14.2 Lung Volume & DLCO Calculations/Corrections 14.3 Blood Gas & CO-oximetry Derived Calculations 14.4 Exercise, Oximetry & Special Test Calculations

15 Evaluating Result Reliability

15.1 Spirometry & Lung Volume Reliability 15.2 DLCO & Exercise Test Reliability 15.3 ABG, Monitoring & QC Reliability

16 Clinical Implications & Reporting

16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity 16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context

16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context

Key Takeaways Explain This Topic AI

Isolated low DLCO prompts a technologist-level differential (emphysema, ILD, anemia, pulmonary hypertension, technical factors)—report the finding and quality flags, not a single disease claim.

High DLCO contexts include asthma (sometimes), polycythemia, left-to-right shunt, recent exercise, and occasionally obesity-related increases—again as associations, not diagnoses.

ABG pattern literacy separates primary respiratory vs metabolic acid-base processes and recognizes oxygenation failure (hypoxemia) for the report.

Positive bronchoprovocation or significant BD response informs airway hyperresponsiveness/reversibility for the referring clinician when tests meet validity rules.

Exercise desaturation and 6MWT results support oxygen-need and functional-status discussions; laboratory ethics require flagging technical limits and never over-interpreting beyond the data.

Last updated: August 2026

Beyond Spirometry: III.C Special Findings on the Report

Pattern labeling of obstruction and restriction is only part of Domain III.C . The NBRC PFT Examination (high cut / RPFT) also scores clinical implications for DLCO , blood gases , airway response , exercise/oxygen assessments , and the laboratory context in which results are released. Map this section to III.C.1–2 (DLCO implications), III.C.5–8 (ABG/oximetry/related gas-exchange framing), III.C.12–14 (airway responsiveness and related response studies), III.C.15–16 (exercise and ambulatory oxygen context), and III.C.19 (quality management / appropriate reporting).

The technologist’s stance stays consistent: accurate pattern language, quality flags, and clinician-facing implications —not a freestanding medical diagnosis.

Isolated Low DLCO — Technologist Awareness Differential (III.C.1–2)

A reduced DLCO (and often DLCO/VA interpretation per lab practice) with or without volume/spirometry context is a common exam stem. At technologist awareness level , think in categories:

  • Category Why DLCO falls Report-adjacent cues
  • Emphysema / loss of alveolar-capillary surface Destroyed surface area Often with obstruction + hyperinflation

Interstitial lung disease (ILD) / alveolar-capillary thickening Diffusion path / membrane impairment Often restriction + low TLC when volumes done

  • Anemia Less Hb to bind CO Check Hb correction practice; clinical Hb if available
  • Pulmonary hypertension / vascular loss Reduced effective capillary bed May be out of proportion to volumes

Technical underestimation Leak, Valsalva, incomplete inspiration, wrong breath-hold, analyzer/QC issues III.B reliability first—do not “diagnose ILD” from a bad maneuver

Isolated low DLCO (spirometry and TLC relatively preserved) still generates a differential , not a single answer: early emphysema, vascular disease, anemia, occult ILD, or technical artifact. Your job on the exam is to recognize plausible associations and prioritize technical validity , then report the numeric DLCO (with corrections used) clearly.

Case vignette E — Isolated low DLCO. TLC normal, spirometry normal, DLCO 55% predicted on two acceptable maneuvers, Hb low on chart. Implication literacy: reduced DLCO may be partly explained by anemia; ensure Hb correction policy is applied and do not invent pure emphysema from DLCO alone.

Case vignette F — Low DLCO + restriction. TLC 65% predicted, ratio high-normal, DLCO severely reduced. Implication literacy: pattern supports restrictive process with impaired gas transfer—consistent with ILD-type physiology for the clinician; still not a histologic diagnosis on the PFT report.

High DLCO Contexts

Elevated DLCO is less common on stems but high-yield when it appears:

Context Mechanism sketch Reporting caution

Asthma (some patients) Increased pulmonary blood volume / recruitment possible Association only; not diagnostic alone

  • Polycythemia More Hb available for CO uptake Note Hb; high DLCO may track Hct
  • Left-to-right shunt Increased pulmonary blood flow Clinical correlation required
  • Exercise (recent) Increased cardiac output / recruitment Timing of test matters

Obesity (sometimes) Increased blood volume / recruitment effects reported in literature contexts Do not over-call; note body habitus on report as measured

If DLCO is unexpectedly high, first exclude technical overestimation (e.g., Valsalva vs Müller issues per method, inspired volume errors, calculation mistakes) before celebrating a “polycythemia pattern.”

ABG Clinical Pattern Recognition (III.C.5–8)

Arterial blood gas implications on the RPFT exam focus on primary process recognition and oxygenation , not full nephrology consults.

Acid-base primary process (simplified reporting literacy)

  • Pattern pH PaCO2 HCO3− (or BE) Primary label literacy
  • Acute respiratory acidosis ↓ ↑ NL (acute) CO2 retention / hypoventilation
  • Acute respiratory alkalosis ↑ ↓ NL (acute) Hyperventilation
  • Metabolic acidosis ↓ NL or compensatory ↓ ↓ Metabolic acid gain/HCO3 loss
  • Metabolic alkalosis ↑ NL or compensatory ↑ ↑ Metabolic base excess

Compensation awareness: Chronic respiratory disorders may show renal HCO3 movement toward normal pH; exam stems often give enough numbers to identify the primary disturbance. Do not invent mixed disorders unless the stem shows dual primary signals.

Oxygenation failure

Hypoxemia: reduced PaO2 (and often reduced SaO2/SpO2 concordance checks).

Relate to A-a gradient literacy when stems provide PAO2/FiO2 context (from Domain III.A calculations).

Hyperoxemia on high FiO2 may be intentional in titration studies—report values, do not moralize.

Case vignette G — ABG. pH 7.28, PaCO2 58 mm Hg, HCO3 near normal, PaO2 52 mm Hg on room air. Implication literacy: acute respiratory acidosis with hypoxemia—consistent with acute ventilatory failure physiology for urgent clinical attention; ensure sample validity (no air bubble, proper timing) was already addressed in procedures/reliability.

CO-oximetry adds dyshemoglobin context (COHb, MetHb) when measured—elevated COHb has carbon monoxide exposure implications; MetHb has methemoglobinemia implications. Report measured fractions; do not guess toxin sources without history.

  • Positive Airway Response: Bronchoprovocation and BD (III.C.12–14)
  • Bronchoprovocation (e.g., methacholine, mannitol, exercise challenge—protocol per lab)

A positive challenge (FEV1 fall meeting threshold at a provocative concentration/dose or protocol endpoint) supports airway hyperresponsiveness for the referring clinician—often used in asthma evaluation pathways.

Result Implication literacy Limits

Positive Supports AHR; clinically relevant when pretest probability and technique are sound Not a standalone “asthma certificate”

  • Negative AHR not demonstrated under test conditions Does not always exclude asthma
  • Inconclusive Poor quality spirometry steps, early stop, or protocol incomplete Do not force positive/negative
  • Bronchodilator response (revisit in special-findings frame)

Significant BD response → reversible component of airflow limitation useful for management discussions. Pair with residual post-BD obstruction language when the ratio/FEV1 remain abnormal.

Safety/reporting ethics: Document symptoms, SpO2 if monitored, and reasons for stopping a challenge early. Never “nudge” a near-threshold fall into positive by selecting a bad post-dose effort.

Exercise Desaturation and 6MWT / Field Tests (III.C.15–16)

Field walking tests and monitored exercise link PFTs to functional status and oxygen need .

Finding Clinical implication literacy for report

Desaturation on 6MWT (SpO2 fall meeting lab/clinical thresholds) Supports discussion of exertional hypoxemia / O2 assessment need

  • Distance walked / stops Functional capacity signal; compare to reference or prior visits when available
  • Recovery pattern How quickly SpO2 recovers; symptom scores (Borg) if collected
  • O2 titration results Flow that maintains target SpO2 during walking protocol

Contraindication stop Chest pain, severe dyspnea, arrhythmia flags—stop and document; do not complete a “pretty” distance at patient risk

Case vignette H — 6MWT. Room-air SpO2 falls from 95% to 86% at 250 m with recovery to 94% seated. Implication: exertional desaturation documented—relevant to oxygen evaluation and functional limitation; ensure oximeter quality and walking protocol validity. This is not automatic lifelong continuous O2 prescription by the technologist—it is data for the ordering clinician .

Laboratory Quality Management and Reporting Ethics (III.C.19)

Clinical implications only help patients when reports stay honest.

Do

Report what was measured , with units , reference basis , and pre/post or serial context .

Flag technical limitations (submaximal efforts accepted only with comment, single acceptable DLCO, leak-prone volume method, ear vs finger SpO2 doubts).

Separate pattern language (“obstructive pattern,” “reduced DLCO”) from disease names when the order is PFT-only.

Escalate critical values (severe hypoxemia, unsafe challenge response) per lab policy .

Do not

Over-interpret a single noisy number into a definitive rare diagnosis.

Suppress inconvenient QC flags to make a “cleaner” chart.

Change selected best efforts after the fact to manufacture a BD or challenge result.

Ignore legal/ethical scope: the RPFT reports and explains physiologic findings ; the physician integrates diagnosis and therapy.

Ethical scenario Correct action

Borderline methacholine at last dose with cough and poor effort Report inconclusive / invalid step—not forced positive

DLCO low but inspired volume only 70% of VA target Flag technical limitation; retest if possible

Referring office wants “COPD stage” from one FEV1 Provide pattern + %predicted/z-score; avoid unauthorized staging systems without clinical synthesis

  • 6MWT stopped for chest pain at 80 m Document stop reason and SpO2; do not invent a full-distance result
  • Putting III.C Together — Mini Integrated Cases

Case I — Emphysema-leaning constellation (awareness only). Obstruction, hyperinflation, low DLCO, exertional desaturation on 6MWT. Report: obstructive pattern with air trapping, reduced DLCO, documented walk desaturation. Clinician synthesizes emphysema likelihood.

Case J — ILD-leaning constellation. Restriction (low TLC), low DLCO, resting or exercise hypoxemia, tall peaked loops. Report: restrictive pattern, impaired DLCO, gas-exchange limitation on exercise if tested.

Case K — Asthma pathway data. Normal baseline spirometry, positive bronchoprovocation or large BD response on another day, high-normal/high DLCO sometimes. Report: AHR positive or significant reversibility—each with numeric criteria met.

Case L — Technical trap. “Restriction + low DLCO” from incomplete spirometry and a leaked DLCO. Correct path: fix reliability first; withhold clinical disease storytelling until numbers are real.

Domain Map and Final RPFT Stance

  • DCO focus Clinical implications skill
  • III.C.1–2 Low/high DLCO associations + technical first
  • III.C.3–4, 17–18 Patterns, severity framing, serial change (Section 16.1)
  • III.C.5–8 ABG primary acid-base + oxygenation literacy
  • III.C.12–14 BD and bronchoprovocation meaning/limits
  • III.C.15–16 Exercise/6MWT desaturation and functional/O2 context
  • III.C.19 Ethical reporting, QC honesty, no over-call

Domain III.C closes the PFT data-management arc: calculate and select reference values ( III.A ), judge reliability ( III.B ), then state clinical implications that help the care team without exceeding technologist scope. Master the differentials for DLCO , the primary patterns for ABG , the meaning of airway response and exercise desaturation , and the ethics of what not to say —that combination is high-yield for RPFT and high-value for patients.